Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01806714 · ClinicalTrials.gov registry record · NA
Text Reminders to Immunize in a Managed Care Organization
A NA study of Human Papilloma Virus, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 3,812
- Enrollment target
- 1
- Study location
NCT01806714: Completed NA study of Human Papilloma Virus, sponsored by University of Rochester.
NCT01806714 is a NA study of Human Papilloma Virus that has completed, run by University of Rochester. The registered enrollment target is 3,812 participants, below the 8,344-participant average among 39 other Human Papilloma Virus trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01806714, a NA study of Human Papilloma Virus, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,812 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to evaluate the effectiveness of a managed care-based HPV vaccination reminder/recall system using a randomized controlled trial (RCT) across diverse practices and patient populations. The trial will measure the effectiveness of text messaging reminder/recall on (a) improving initiation and (b) completion rate of the HPV vaccine series; (c) decreasing the time between vaccine doses; and (d) improving rates of preventive visits for adolescents The hypotheses are that text-messaged reminders to parents of adolescents will result in improved rates of HPV vaccine series initiation, HPV vaccine series completion, will decrease the intervals between vaccine doses and will improve rates of preventive care among adolescents. Parents receiving specific text-messaged reminders about services (i.e. HPV vaccination, well child care visits) for which their adolescent is due will be compared to a control group of parents receiving general health tips through text messages.
Primary Outcome
Participants who received HPV vaccine dose 1 Kaplan-Meier failure function
Conditions Studied
Interventions
- OTHER Text-based reminder for recommended HPV vaccine or WCC
- OTHER Non-specific text-based reminder (general health tip)
Study Locations (1)
New York
- University of Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,812 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-12 |
| Phase | NA |
What the finished NCT01806714 record still lists
NCT01806714 is an interventional study that assigns participants to a tested intervention. Its 3,812 participants enrollment target places it among the larger protocols in the corpus, below the 8,344-participant average among 39 other Human Papilloma Virus trials with a reported enrollment target (54% lower).
The record links to 1 condition, with Human Papilloma Virus appearing as the primary indexed condition, and to 2 interventions - of which Text-based reminder for recommended HPV vaccine or WCC is the first listed.
NCT01806714 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01806714 about?
NCT01806714 is a clinical study titled "Text Reminders to Immunize in a Managed Care Organization". The purpose of the study is to evaluate the effectiveness of a managed care-based HPV vaccination reminder/recall system using a randomized controlled trial (RCT) across diverse practices and patient populations. The trial will measure the effectiveness of text messaging reminder/recall on (a) impro...
What is the current status of trial NCT01806714?
This trial is currently completed. It is a NA study. The enrollment target is 3,812 participants. The study started on 2013-07. Estimated completion is 2014-12.
What conditions does trial NCT01806714 study?
This clinical trial studies the following conditions: Human Papilloma Virus.
What interventions are being tested in trial NCT01806714?
The interventions under investigation include: Text-based reminder for recommended HPV vaccine or WCC (OTHER), Non-specific text-based reminder (general health tip) (OTHER).
Who is sponsoring clinical trial NCT01806714?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01806714 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Human Papilloma Virus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01806714's enrollment target sits among peer trials
3,812 4th of 39 higher than 36 of 39 other Human Papilloma Virus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Human Papilloma Virus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine
RECRUITING · NA
-
PopSci CHW4CervixHealth
RECRUITING · NA
-
Advancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study
RECRUITING · NA
-
Provider Recommendation and HPV Vaccination
RECRUITING · NA
-
Impact of Standing Orders Optimization
ACTIVE NOT RECRUITING · NA
-
Development of a Self-collection Device for Cervical Cancer Screening
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04573660 · 3,784 participants
Abbott Vascular Medical Device Registry
- NCT07087613 · 3,850 participants
Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG
- NCT06172660 · 3,750 participants
Real-World Effectiveness of Perinatal RSV Immunoprophylaxis
- NCT06298253 · 3,750 participants · NA
Behavioral Economics to Implement a Traffic Light Nutrition Ranking System: Study 2
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia